In NSCLC, NRF2 activation is associated with the overexpression of NADPH-producing enzymes and NADPH oxidases (NOX2 and NOX4), which together help maintain redox balance and fuel critical biosynthetic pathways essential for cancer cell growth [181,182]. Here, NFE2L2 is linked to non-small cell lung carcinoma.